SPRY — ARS Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(SPRY)

ARS Pharmaceuticals, Inc.

Live chart and latest SPRY stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

SPRY News

Canada clears first needle-free epinephrine for severe allergies

Apr 15, 2026 ChartMill

SPRY Stock Price, Quote & Chart | ARS PHARMACEUTICALS INC (NASDAQ:SPRY)

Apr 10, 2026 Yahoo Finance

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Mar 2, 2026 Seeking Alpha

ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)

Mar 11, 2026 simplywall.st

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock Catapults 25% Though Its Price And Business Still Lag The Industry

Jan 10, 2026 Investing.com

Leerink raises ARS Pharmaceuticals stock price target on sales expansion

Mar 10, 2026 Yahoo Finance

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

Mar 9, 2026 Stock Titan

FDA lets younger children use needle-free neffy once they reach 33 lbs.

Mar 27, 2026 Seeking Alpha

ARS Pharmaceuticals: Climbing Neffy Sales And Global Expansion Could Re-Rate The Stock

Feb 13, 2026 Investing.com

Raymond James reiterates Strong Buy on ARS Pharmaceuticals stock

Mar 2, 2026 Yahoo Finance

Assessing ARS Pharmaceuticals (SPRY) Valuation After A 19.3% Single Day Share Price Jump

Jan 10, 2026 Stock Titan

Millennium Managers Hold 5.4% of ARS Pharmaceuticals (NASDAQ: SPRY)

Mar 24, 2026 Yahoo Finance

ARS Pharma (SPRY) Gains China Approval for Neffy, Roth Reiterates Buy Rating

Jan 9, 2026 Yahoo Finance

How Investors May Respond To ARS Pharmaceuticals (SPRY) Expanding EURneffy Pediatric Use Across Europe

Feb 2, 2026 Yahoo Finance

ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates